483 Tapemark Company Mar 2017

483 Tapemark Company Mar 2017

James Ireland FDA, Anthony Ladner FDA$119.00 - Available Now

FDA investigators audited the Tapemark Company - Saint Paul, MN, United States facility and issued inspectional observations (via FDA 483) on 29 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Mar 2017
  • Location: Saint Paul, United States
  • FEI: 2182681
Add To Cart